Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.86 1.45%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics P/B Ratio 2011-2024 | RVNC

Annual P/B Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.16 200 13.1 3.94 4.3 4.38 3.82 3.05 1.99 1.77 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
200 -3.16 23.3